Regulation of angiostatic chemokines driven by IL-12 and IL-27 in human tumors

Antiproliferative Activity of IL-27 on Melanoma

(2014) T. Yoshimoto et al.   JOURNAL OF IMMUNOLOGY

Interleukin-27 and interleukin-23 modulate human plasmacell functions

(2011) C. Cocco et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells

(2010) C. Cocco et al.   BLOOD

Interleukin-27 Acts as Multifunctional Antitumor Agent in Multiple Myeloma

(2010) C. Cocco et al.   CLINICAL CANCER RESEARCH

CXCL12 (SDF-1)/CXCR4 Pathway in Cancer

(2010) B. A. Teicher et al.   CLINICAL CANCER RESEARCH

Direct inhibition of human acute myeloid leukemia cell growth by IL-12

(2010) Elisa Ferretti et al.   IMMUNOLOGY LETTERS

IL-12 and IL-27 Sequential Gene Therapy via Intramuscular Electroporation Delivery for Eliminating Distal Aggressive Tumors

(2010) Shiguo Zhu et al.   JOURNAL OF IMMUNOLOGY

Phase-I clinical trial of IL-12 plasmid/lipopolymer complexes for the treatment of recurrent ovarian cancer

(2009) K Anwer et al.   GENE THERAPY

Phase II study of interleukin-12 for treatment of plateau phase multiple myeloma (E1A96): A trial of the Eastern Cooperative Oncology Group

(2009) Martha Q. Lacy et al.   LEUKEMIA RESEARCH

IL-12 Can Target Human Lung Adenocarcinoma Cells and Normal Bronchial Epithelial Cells Surrounding Tumor Lesions

(2009) Irma Airoldi et al.   PLoS One

Constitutive expression of IL-12R 2 on human multiple myeloma cells delineates a novel therapeutic target

(2008) I. Airoldi et al.   BLOOD